Test Component | Pretest Mean Score (%) | Immediate Posttest Mean Score | 6-Month Posttest Mean Score | ||
---|---|---|---|---|---|
% | OR† (95% CI) | % | OR (95% CI) | ||
Overall score‡ | |||||
All lesions (n = 25) | 36.1 | 46.7 | 1.6 (1.4–1.9) | 41.3 | 1.3 (1.1–1.5) |
Malignant (n = 15) | 38.7 | 46.9 | 1.5 (1.2–1.8) | 43.1 | 1.2 (1.0–1.5) |
Benign (n = 10) | 32.1 | 46.3 | 1.9 (1.6–2.4) | 38.6 | 1.4 (1.0–1.8) |
Diagnosis score | |||||
All lesions (n = 25) | 41.5 | 51.9 | 1.6 (1.4–1.8) | 44.8 | 1.1 (1.0–1.4) |
Malignant (n = 15) | 39.4 | 48.8 | 1.5 (1.3–1.9) | 44.0 | 1.2 (1.0–1.5) |
Benign (n = 10) | 44.8 | 56.7 | 1.7 (1.3–2.1) | 46.0 | 1.0 (0.8–1.4) |
Management score | |||||
All lesions (n = 25) | 72.9 | 78.4 | 1.4 (1.2–1.7) | 77.3 | 1.3 (1.1–1.6) |
Referred (n = 15) | 86.6 | 82.8 | 0.7 (0.5–0.9) | 85.1 | 0.8 (0.6–1.1) |
Reassured (n = 10) | 52.3 | 71.9 | 2.8 (2.2–3.6) | 65.7 | 2.1 (1.5–2.8) |
↵* All 54 participants took the pretest and immediate posttest; 48 (89%) took the 6-month posttest.
↵† Odd ratio (OR) is an estimate of relative risk and is an indication of how much better the posttest scores of participants are compared to the pretest score. See the Analysis section.
↵‡ Includes both diagnosis and management.
CI, confidence interval.